The Drug Development Letter
Vinay Prasad, Timothée Olivier, Alyson Haslam, Owen Stratton, Mariana B. Caiado Ferreira, John-John Schnog, Sahar van Waalwijk, Susanne Osanto, Ashley Nee, Michael Samson, Bart PenninxDr Prasad currently works at the US FDA. The writings on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
| Platform |  | Pricing | Only free issues | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 104 | Subscribers | Read | drugdevletter.com |
Curious about how many subscribers The Drug Development Letter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Latest Issues
Recent posts by this newsletter. Browse the email archive.
Can I confidently say to patients that a 3-year structured exercise program may save their lives? The CHALLENGE trial (part 2)
A brief recap: the CHALLENGE trial enrolled patients treated for colon cancer and adjuvant chemotherapy and randomized them to receive either health-educational materials only (control patients), or similar materials plus a 3-year supervise...
The online BREAKING-ICE App© out in The Lancet Oncology !
The online BREAKING-ICE App© has been published recently in The Lancet Oncology, co-authored with Vinay Prasad and Alyson Haslam.
Does a 3-year structured exercise program save lives? Part 1
I want to start by congratulating the authors, the investigators, and the patients for participating and conducting the CHALLENGE trial, presented during the ASCO 2025 meeting, one of the biggest oncology conference worldwide.
Authors
The writers behind this newsletter.
Hematology Oncology Medicine Health Policy Epidemiology Professor
Swiss oncologist at Geneva University Hospital. Research on trial methodology, health policy, and critical appraisal. I joined Vinay Prasad’s research lab in November 2021. Geneva Ethics Committee. Co-EiC ESMO Rare Cancers. No COI. Views mine.
Health policy researcher at UCSF
medical student at Wayne State University School of Medicine
MD, MSc History and Philosophy of Science. Internal Medicine resident. “Where is the wisdom we have lost in knowledge?”
Internist-hematologist/medical oncologist Curaçao
Pharmacist Medicine & Society (PharmD-PhD), National Funder’s Committee for Evaluation of Specialised Medicines and Companion Diagnostics, CZ. Associate Professor of Medical Oncology and Accessibility of Medicine, LUMC, NL
Medical Oncologist. Professor of Oncology, LUMC, NL. Chairperson European Uro-Oncology Group.
Medical Student at Warren Alpert Medical School of Brown University
Radiation Oncologist with special interest in critical appraisal of clinical trials and guidelines.
PhD-student at Amsterdam UMC
Frequently Asked Questions
How can I access the email archive for The Drug Development Letter?
You can find recent issues that have been published by The Drug Development Letter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Drug Development Letter have?
To see how many people subscribe to The Drug Development Letter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Drug Development Letter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Drug Development Letter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Drug Development Letter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Drug Development Letter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to The Drug Development Letter?
Scroll up to where it says Similar Newsletters to see other publications like The Drug Development Letter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Drug Development Letter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.